Jan Silverman, MD

Articles by Jan Silverman, MD

Paraganglioma: A Potentially Challenging Tumor

ByMark Trombetta, MD,Jan Silverman, MD,Athanasios Colonias, MD,Vincent Lee, MD,Alok Mohanty, MD,David Parda, MD

March 1st 2008

The development of metastatic disease in patients with paraganglioma is an unusual and challenging event. This case report and review describes the specific features of this disease and the multiple therapeutic options.

Latest Updated Articles

Paraganglioma: A Potentially Challenging Tumor
March 1st 2008

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)